Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Emergence of Dengue Virus Serotype 3, Lineage III_B.3.2, Angola
Jocelyne Neto de Vasconcelos1, Ingra M. Claro1, Raissa Heloisa de Araujo Eliodoro1, Filipe R.R. Moreira, Amilton Pereira, Luzia Samuel, Esménia Coelho Rocha, Eusébio Manuel, Nelson Mapenzi-Kashali, Fiston Cikaya Kankolongo, Darlan S. Cândido, Jaqueline Goes de Jesus, Gilda Mariano, Sofia Sousa, Carina Clemente, Cláudia Muenga, Ilaria Dorigatti, William M. de Souza, Charles Whittaker, Victoria M. Cox, Wes Hinsley, Nicholas Loman, Joshua Quick, Placide Mbala2, Nuno R. Faria2, Joana Morais2 , and on behalf of the FEEVIR Consortium3
Author affiliation: Centro de Investigação em Saúde de Angola, Bengo, Angola (J.N. de Vasconcelos); Ministry of Health, Luanda, Angola (J.N. de Vasconcelos, A. Pereira, L. Samuel, E. Manuel, J. Morais); Imperial College London, London, UK (J.N. de Vasconcelos, D.S. Cândido, I. Dorigatti, C. Whittaker, V.M. Cox, W. Hinsley, N.R. Faria); Universidade de São Paulo, São Paulo, Brazil (I.M. Claro, R.H. de Araujo Eliodoro, E. Coelho Rocha, J.G. de Jesus, N.R. Faria); University of Kentucky, Lexington, Kentucky, USA (I.M. Claro, W.M. de Souza); Federal University of Rio de Janeiro, Rio de Janeiro, Brazil (F.R.R. Moreira); Universidade Agostinho Neto, Luanda (E. Manuel, J. Morais); Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo (N. Mapenzi-Kashali, F. Cikaya Kankolongo, P. Mbala); Bahiana School of Public Health, Bahia, Brazil (J.G. de Jesus); Cligest Clinic, Luanda (G. Mariano, S. Sousa, C. Clemente, C. Muenga); University of Birmingham, Birmingham, UK (N. Loman, J. Quick); Université de Kinshasa, Kinshasa (P. Mbala)
Suggested citation for this article
Abstract
We detected dengue virus serotype 3 in 11.8% (16/136) of febrile patients in Luanda Province, Angola, during April and July 2024. Our genetic analyses reveal that dengue virus serotype 3 lineage III_B.3.2 probably was imported from the Americas into Angola in late 2022 and then spread through local transmission.
Dengue virus (DENV) is transmitted primarily by Aedes aegypti mosquitoes and is the most widespread arbovirus globally (1). DENV is classified into 4 serotypes, DENV-1–4, each comprising several genotypes and lineages (2). Secondary infection with a heterologous serotype can increase disease severity through antibody-dependent enhancement (3).
In Africa, DENV incidence has risen sharply (4). Although malaria remains the dominant febrile illness, climate change might be increasing suitability for Aedes mosquito–borne arboviruses in the continent. In Angola, dengue became a notifiable disease in 2017. Molecular surveillance has previously confirmed the circulation of DENV-1 (2013) (5), and DENV-2 (2018) (6). In April 2024, four suspected dengue cases in Luanda Province reported to Angola’s Ministry of Health prompted an outbreak investigation.
We tested a convenience sample of 136 febrile patients (median age 33.5 years, interquartile range [IQR] 13–39 years) who visited 3 clinics in Luanda Province during April–November 2024. We tested residual diagnostic samples for DENV, chikungunya virus (CHIKV), and Zika virus (ZIKV) by using real-time reverse transcription PCR (Taqman Arbovirus Triplex Kit; Thermo Fisher Scientific, https://www.thermofisher.com/us/en/home.html.html) at the National Institute for Health Research under Angola’s National Arbovirus Surveillance program and in accordance with the National Ethics Committee of the Ministry of Health.
Of 136 samples, 16 (11.8%) were positive for DENV (Figure; Appendix Figure 1). Median cycle threshold was 29.7 (IQR 26.9–32.1), and median patient age was 31.5 years (IQR 10.5–40.5 years). None tested positive for CHIKV or ZIKV. Positive cases were geographically distributed across 3 municipalities in Luanda Province: Luanda (9/16 [56.3%]), Viana (6/16 [37%]), and Talatona (1/16 [6.3%]) (Appendix Table 1). We detected positive cases during April–July 2024 and detected no cases during August–November (dry season). Two positive case-patients required platelet transfusion, consistent with severe dengue and possible secondary infection (Appendix Table). Climatic suitability for Ae. aegypti mosquito transmission (index P, lagged +2 months) remained above 1 during September–July, confirming permissive conditions for transmission during the detection window (Figure; Appendix Figure 1).
We attempted sequencing of all 16 positive samples by using a multiplex PCR protocol on the Oxford Nanopore MinION platform (https://nanoporetech.com) (Appendix). We recovered 6 near-complete and partial DENV-3 sequences (median coverage 37.6%, IQR 21.5%–57.1%) (Figure; Appendix Table). All were classified as DENV-3 lineage III_B.3.2. Lower cycle threshold values correlated with higher horizontal sequencing coverage (r ρ = –0.44; p = 0.1) (Appendix Figure 2). Maximum-likelihood phylogenetic analysis showed Angola sequences clustering into a single clade (bootstrap = 100) (Figure; Appendix). Molecular clock analysis estimated their common ancestor to be around late October 2022 (95% Bayesian CI April 2022–March 2023) (Appendix Figures 4–6).
Phylogenetic analyses revealed that Angola sequences were more closely related to viruses from the Americas (Figure; Appendix Figures 4, 5). However, undersampling and inequities in sequencing capacity could result in alternative epidemiologic scenarios, so we compared air passenger traffic into Angola (Appendix Figure 6) with lineage III_B.3.2 sampling intensity measured as the number of publicly available genomes for this lineage per million inhabitants in any given country where this lineage had been detected (according to GenBank data as of April 25, 2025). We observed a moderate correlation (Pearson r = 0.55; p = 0.042), suggesting that countries with frequent travel links, particularly Cuba, harbored closely related strains. However, those findings should be interpreted cautiously given limited recent genomic DENV-3 data from several regions, including Brazil (Appendix Figures 7–9).
We document the emergence of DENV-3 lineage III_B.3.2 in Luanda, Angola, where the lineage probably was introduced from the Americas in late 2022, followed by local transmission across Luanda Province. Seasonal detection patterns aligned with climatic suitability for Aedes mosquito–borne transmission.
The emergence of DENV-3 in Angola raises concerns about disease severity given prior circulation of DENV-1 and DENV-2. In the absence of large-scale vaccination or vector-control programs, strengthening laboratory and clinical surveillance will be critical for outbreak detection and patient management (6). The risk extends beyond Luanda Province, which accounts for 27% of the country’s 38 million residents (https://data.worldbank.org/indicator/SP.POP.TOTL?locations=AO). Ae. aegypti mosquitos are widespread in the country (7), and climate projections indicate increasingly intense wet seasons in coastal Angola (8), further increasing the risk for arboviral transmission.
Given Angola’s history of Aedes mosquito–borne outbreaks, including yellow fever (2015–2016) (9) and Zika virus (2016–2017) (10), investment in laboratory capacity, capacity retention, and vector surveillance is urgent. Improved preparedness will help to mitigate the risk for sustained DENV transmission and related public health consequences.
Ms. de Vasconcelos is a public health researcher, PhD candidate at Imperial College London, and head of the Centro de Investigação em Saúde de Angola. Her research focuses on epidemiological surveillance and the molecular and genomic characterization of emerging and reemerging infectious diseases in Angola. Dr. Claro is a postdoctoral scholar at the University of Kentucky. Her research focuses on viral genomics and epidemiology of emerging viruses, with an emphasis on developing and improving strategies for detection, preparedness, and response to viral outbreaks affecting humans and animals.
Acknowledgments
We acknowledge the use of meteorological data from J. Muñoz Sabater, which was downloaded from the Copernicus Climate Change Service Climate Data Store: ERA5-Land hourly data from 1950 to present. The results contain modified Copernicus Climate Change Service information for 2023. Neither the European Commission nor the European Centre for Medium-Range Weather Forecasts is responsible for any use that may be made of the Copernicus information or data it contains.
Research reported in this study was supported by the United Nations Foundation (WHO International Pathogen Surveillance Network Catalytic Grant Fund; FEEVIR: G-23279; RT-Meta: G-23387), the ISPF Global Development Hub ODA Project Accelerator, Wellcome Trust (DeZi Network: 316633/Z/24/Z; ARTIC2: 204843/Z/16/Z), the Burroughs Wellcome Fund (no. 1022448), the BONGOLA project (no. 11/MESCTI/PDCT/2020), and Instituto Serrapilheira, ANBRA project (no. 05-2021/grant no. 6685). We also acknowledge funding from the MRC Centre for Global Infectious Disease Analysis (MR/X020258/1), funded by the UK Medical Research Council. This United Kingdom–funded award is carried out in the frame of the Global Health EDCTP3 Joint Undertaking.
Members of the FEEVIR Consortium: Aracelli Acevedo Colina, Luís Miguel Costa, Rogério Diemba, Reginaldo Samuel, António Cassinda, and Domingos Catraio.
References
- Lim A, Shearer FM, Sewalk K, Pigott DM, Clarke J, Ghouse A, et al. The overlapping global distribution of dengue, chikungunya, Zika and yellow fever. Nat Commun. 2025;16:3418. DOIPubMedGoogle Scholar
- Hill V, Cleemput S, Pereira JS, Gifford RJ, Fonseca V, Tegally H, et al. A new lineage nomenclature to aid genomic surveillance of dengue virus. PLoS Biol. 2024;22:e3002834. DOIPubMedGoogle Scholar
- Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, et al. Antibody-dependent enhancement of severe dengue disease in humans. Science. 2017;358:929–32. DOIPubMedGoogle Scholar
- Mercy K, Youm E, Aliddeki D, Faria NR, Kebede Y, Ndembi N. The looming threat of dengue fever: the Africa context. Open Forum Infect Dis. 2024;11:ofae362. DOIGoogle Scholar
- Centers for Disease Control and Prevention (CDC). Ongoing dengue epidemic – Angola, June 2013. MMWR Morb Mortal Wkly Rep. 2013;62:504–7.PubMedGoogle Scholar
- Neto Z, Martinez PA, Hill SC, Jandondo D, Thézé J, Mirandela M, et al. Molecular and genomic investigation of an urban outbreak of dengue virus serotype 2 in Angola, 2017-2019. PLoS Negl Trop Dis. 2022;16:e0010255. DOIPubMedGoogle Scholar
- Marquetti Fernández M, Arletty T, Cani P, Flores Y. Longitudinal spatial distribution of Aedes aegypti (Diptera: Culicidae) during the yellow fever epidemic in Angola, 2016. Glob J Zool. 2019;4:001–6. DOIGoogle Scholar
- Soares PMM, Careto JAM, Lima DCA. Future extreme and compound events in Angola: CORDEX-Africa regional climate modelling projections. Weather Clim Extrem. 2024;45:100691. DOIGoogle Scholar
- Kraemer MUG, Faria NR, Reiner RC Jr, Golding N, Nikolay B, Stasse S, et al. Spread of yellow fever virus outbreak in Angola and the Democratic Republic of the Congo 2015-16: a modelling study. Lancet Infect Dis. 2017;17:330–8. DOIPubMedGoogle Scholar
- Hill SC, Vasconcelos J, Neto Z, Jandondo D, Zé-Zé L, Aguiar RS, et al. Emergence of the Asian lineage of Zika virus in Angola: an outbreak investigation. Lancet Infect Dis. 2019;19:1138–47. DOIPubMedGoogle Scholar
Figures
- Figure. Maximum-likelihood phylogenetic tree for dengue virus serotype 3, lineage III_B.3.2, Angola. Tips are colored by country of infection. Luanda sequences are shown in red (Appendix Figures 5, 6, https://wwwnc.cdc.gov/EID/article/31/11/25-1079-App1.pdf)….
- Appendix.
Suggested citation for this article: de Vasconcelos JN, Claro IM, de Araujo Eliodoro RH, Moreira FRR, Pereira A, Samuel L, et al. Emergence of dengue virus serotype 3, lineage III_B.3.2, Angola. Emerg Infect Dis. 2025 Nov [date cited]. https://doi.org/10.3201/eid3111.251079
DOI: 10.3201/eid3111.251079
Original Publication Date: December 04, 2025
Table of Contents – Volume 31, Number 11—November 2025
file_external Top’); return p; } function AppendTopLinks() { var allChildren = $(‘#mainbody’).children(); var sections =
; for (var i = 0; i 1) $(sections).append(CreateTopLinkElement()); } AppendTopLinks(); $(document).ready(function () { $(‘#pdfPopover’).popover({ html: true, placement: ‘top’, container: $(‘#pdfPopover’).closest(‘div’), content: “This file contains the article and technical appendix, not including any Excel files.” }); $(‘#pdfPopover’).on(‘inserted.bs.popover’, function () { // CDC template js was removing close button for some reason… // so put in close button, and hook up hide on click $(‘#pdfPopover’).closest(‘div’).find(‘.popover-body’).prepend(“
Emergence of Dengue Virus Serotype 3, Lineage III_B.3.2, Angola
Volume 31, Number 11—November 2025
Article Views: 5
Data is collected weekly and does not include downloads and attachments. View data is from .
Time period First 3 Months Last 3 Months Last Year Last 2 Years All Data
Altmetrics
Click a source for Altmetric details
What is the Altmetric Attention Score?
The Altmetric Attention Score for a research output provides an indicator of the amount of attention that it has received. The score is derived from an automated algorithm, and represents a weighted count of the amount of attention Altmetric picked up for a research output.
author.includes(‘GAIHN-HAI Team’)); authors.splice(spanIndex, 1); const lastAuthor = authors.pop().trim(); authors.push(spanElement.trim()); authors.push(‘and ‘ + lastAuthor); authorsDiv.innerHTML =authors.join(‘, ‘); } }; ]]>
Source
Our Pill Pass® Drug List is only $6.99 or less and Shipping is FREE!

